New Results
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies
Hao Zhou, View ORCID ProfileTakuya Tada, View ORCID ProfileBelinda M. Dcosta, View ORCID ProfileNathaniel R. Landau
doi: https://doi.org/10.1101/2022.02.15.480166
Hao Zhou
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Takuya Tada
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Belinda M. Dcosta
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA
Nathaniel R. Landau
1Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA

Article usage
Posted February 24, 2022.
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies
Hao Zhou, Takuya Tada, Belinda M. Dcosta, Nathaniel R. Landau
bioRxiv 2022.02.15.480166; doi: https://doi.org/10.1101/2022.02.15.480166
Subject Area
Subject Areas
- Biochemistry (7545)
- Bioengineering (5495)
- Bioinformatics (20732)
- Biophysics (10294)
- Cancer Biology (7951)
- Cell Biology (11610)
- Clinical Trials (138)
- Developmental Biology (6586)
- Ecology (10168)
- Epidemiology (2065)
- Evolutionary Biology (13578)
- Genetics (9520)
- Genomics (12817)
- Immunology (7906)
- Microbiology (19503)
- Molecular Biology (7641)
- Neuroscience (41982)
- Paleontology (307)
- Pathology (1254)
- Pharmacology and Toxicology (2192)
- Physiology (3259)
- Plant Biology (7018)
- Synthetic Biology (1947)
- Systems Biology (5418)
- Zoology (1113)